Resources
About Us
Meticulous Research® –leading global market research company published a research report titled “Patient Registry Software Market by Type (Diabetes, Cancer, Rare Diseases, CVD, Orthopedic, Drugs, Device), Delivery (On premise, Cloud), Functionality (PHM, HIE, POC, Research), Database (Public, Commercial), Pricing Model, End User – Global Forecast to 2023”.
According to this latest publication from Meticulous Research®, the global patient registry software market is expected to grow at a CAGR of 11.0% from 2018 to 2023 to reach USD 1.49 billion by 2023, driven by factors such as continued pressure to curtail rising healthcare costs, growing demand to improve care quality, increasing adoption of EHRs and improving health IT infrastructure, growing application of patient registry data in post-marketing surveillance, and increase in the support from government for value-based care and adoption of patient registries. Moreover, growing emphasis on population health management and proliferating accountable care organizations (ACO), emergence of cloud-based patient registry solutions, and shifting focus towards Patient-Powered Research Networks (PPRNs) offer significant growth opportunities for the market players during the forecast period.
The patient registry software market study presents historical market data in terms of value (2016 and 2017), estimated current data (2018), and forecasts for 2023 by registry type (disease registry, health services registry, and product registry), software (standalone, integrated), pricing model (subscription, ownership), deployment model (on premise, web &cloud), database type (commercial, public), functionality (population health management, patient care management, health information exchange, point-of-care, product outcome evaluation, medical research & clinical studies), and end user (government organizations & third-party administrators, hospitals and medical practices, private payers, pharmaceutical, biotechnology, and medical device companies, research centers). The study also evaluates industry competitors and analyzes the market at a regional and country level.
With the rising prevalence of chronic disease conditions such as diabetes, cardiovascular diseases and asthma, there is a growing need for chronic disease registries that can help manage patients proactively. Moreover, increasing number of initiatives are being taken across the globe to build rare disease patient registries to gain a better understanding of rare diseases. Such efforts contribute to the largest share of patient registry software for disease registries.
Standalone software comprised the major market share in 2017 as these are usually less complex, dedicated, cost-effective and simpler to setup than integrated systems. However, with the trend towards integrated care, healthcare organizations would increasingly consider integrating the use of registries into clinicians’ workflows at the point-of-care, and interfacing registries with EHRs. This in turn will drive the integrated patient registry software market at the highest CAGR during the forecast period.
In 2017, on premise solutions captured a major share owing to concerns related to patient data confidentiality and security on remotely managed servers. However, cloud-based solutions are anticipated to grow at a lucrative rate for their real-time data analysis, easy accessibility, flexibility, scalability, and cost-effectiveness.
Application of patient registry software for population health management (PHM) held a significant market share in 2017 and is also expected to continue to grow at the fastest CAGR owing to government initiatives for encouraging value-based care and PHM programs.
Government organizations and TPAs are currently the major end users of patient registry software. However, hospitals and medical practices are expected to be in the spotlight during the forecast period.
This research report analyzes major geographies and provides a comprehensive analysis of North America (U.S. and Canada), Europe (Germany, U.K., France, Italy, Spain, and RoE), Asia-Pacific (Japan, China, India, and RoAPAC), Latin America, and the Middle East & Africa. North America captured a significant share in 2017 and is expected to register the highest CAGR during the forecast period mainly due to presence of major Health IT companies in the U.S., advanced healthcare and health IT infrastructure, rising demand for structured information by healthcare stakeholders, increasing need to curtail healthcare costs, implementation of the ACA in the U.S., and rising focus on population health management. In addition, significant growth in the number of EHRs, Accountable Care Organizations (ACOs) and health information exchange (HIEs) further supports the greater adoption and fastest growth in this region.
The patient registry software market is highly competitive and fragmented with the presence of some large well-established IT companies and several small and emerging vendors. Some of the key players contributing to the growth of the patient registry software market include Phytel, Inc. (An IBM Corporation Company) (U.S.), Quintiles IMS Holdings, Inc. (U.S.), Liaison Technologies. (U.S.), ImageTrend, Inc. (U.S.), FIGmd, Inc. (U.S.), McKesson Corporation (U.S.) (Change Healthcare), CECity.com Inc. (U.S.) (A Premier, Inc. Company) , Dacima Software Inc. (U.S.), Global Vision Technologies, Inc. (U.S.), ifa Systems AG, (Germany), Syneos Health (U.S.), M2S, Inc. (U.S.), Optum, Inc (A part of UnitedHealth Group Inc) (U.S.), EVADO Pty. Ltd. (Australia), and Velos, Inc. (U.S.) among several others. In the recent past, these companies significantly focused on entering into agreements, partnerships, strategic alliances, and collaborations to expand their product and service offerings, strengthen their global footprint, and augment their market shares.
Download Free Sample Report @ https://www.meticulousresearch.com/download-sample-report/cp_id=4227
Key questions answered in the report-
About Meticulous Research®
Meticulous Research® was founded in 2010 and incorporated as Meticulous Market Research Pvt. Ltd. in 2013 as a private limited company under the Companies Act, 1956. Since its incorporation, the company has become the leading provider of premium market intelligence in North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa.
With the meticulous primary and secondary research techniques, we have built strong capabilities in data collection, interpretation, and analysis of data including qualitative and quantitative research with the finest team of analysts. We design our meticulously analyzed intelligent and value-driven syndicated market research reports, custom studies, quick turnaround research, and consulting solutions to address business challenges of sustainable growth. Meticulous Research® produces global reports and custom studies for North America, Europe, Latin America, Asia-Pacific, and the Middle East and Africa regions. These reports are used by our clients for marketing and strategic planning in various sectors.
Contact Us:
Meticulous Research®
Email- sales@meticulousresearch.com
Contact Sales- +1-646-781-8004
Connect with us on LinkedIn- https://www.linkedin.com/company/meticulous-research
Connect with us on Twitter- https://twitter.com/MeticulousR123
Kenya IVD Market to be Worth $68.66 Billion by 2032
Read More
Cardiac Biomarkers Market to be Worth $10.08 Billion by 2031
Read More
Cytogenetics Market to be Worth $5.5 Billion by 2031
Read More
Metagenomics Market to be Worth $ 6.71 Billion by 2031
Read More
Dental Lasers Market to be Worth $618.7 million by 2032
Read More
Bakuchiol Serum Market to Reach $4.41 Million by 2032
Read More
Burn Care Market to be Worth $4.32 Billion by 2032
Read More
Africa Medical Devices Market to be Worth $7.14 Billion by 2032
Read More
Middle East Medical Devices Market to be Worth $8.8 Billion by 2032
Read More
Surgical Drills Market to be Worth $1.71 Billion by 2032
Read More
Tissue Engineering Market to reach $7.41 Billion by 2032
Read More
Dental Prosthetics Market to be Worth $ 19.6 Billion by 2032
Read More
Whole Genome Sequencing Market to be Worth $7.17 Billion by 2031
Read More
IVD Assay Development Market to be Worth $8.39 Billion by 2031
Read More
Neurogenomics Market to Reach $4.68 Billion by 2031
Read More
India VNA & PACS Market to Reach $341.6 Million by 2031
Read More
China Microarray Market to Be Worth $910.4 Million by 2031
Read More
China Neurogenomics Market to Reach $562.1 Million by 2031
Read More
ELISA Market to be Worth $32.69 Billion by 2032
Read More
DNA Sequencing Market to be Worth $21.30 Billion by 2031
Read More
Oral Care Market to be Worth $70 Billion by 2032
Read More
Spirometer Market to be Worth $1.80 Billion by 2032
Read More
Viral Vaccines Market to be Worth $64.18 Billion by 2031
Read More
Pet Care Market to be Worth $287.96 Billion by 2032
Read More
Regenerative Medicine Market to be Worth $37.27 Billion by 2031
Read More
Hemostats Market to be Worth $5.32 Billion by 2032
Read More
Bioreactors Market to be Worth $39.96 Billion by 2032
Read More
Protein Assays Market to be Worth $4.36 Billion by 2032
Read More
Veterinary API Market to Reach $15.84 Billion by 2031
Read More
Asia-Pacific NGS Automation Market to be Worth $371 Million by 2032
Read More
Latin America NGS Market to be Worth $765.2 Million by 2032
Read More
Biochemical Reagents Market to be Worth $39.61 Billion by 2032
Read More
Microarray Kits Market to be Worth $2.51 Billion by 2032
Read More
Antibody Production Market to Reach $58.35 Billion by 2032
Read More
Middle East IVD Market to be Worth $2.15 Billion by 2032
Read More
Spatial Genomics Market to be Worth $3.23 Billion by 2031
Read More
Asia-Pacific IVD Market to be Worth $36.02 Billion by 2032
Read More
Europe NGS Market to be Worth $6.40 Billion by 2032
Read More
Lab Automation Market to be Worth $11.31 Billion by 2031
Read More
Bioinformatics Market to Reach $31.71 Billion by 2031
Read More
Europe IVD Market to be Worth $39.77 Billion by 2032
Read More
Sequencing Kits Market to be Worth $25.29 Billion by 2031
Read More
Veterinary API Market to Reach $15.84 Billion by 2032
Read More
U.S. Ambulatory EHR Market to be Worth $3.97 Billion by 2031
Read More
Sample Preparation Market to be Worth $12.77 Billion by 2031
Read More
Surgical Robots Market Worth $25.47 Billion by 2032
Read More
Medical Coatings Market Worth $3.32 Billion by 2032
Read More
Digital Therapeutics Market to be Worth $56.34 Billion by 2031
Read More
Liquid Handling Systems Market Worth $6.99 Billion by 2029
Read More
Electrosurgery Market to be Worth $8.99 Billion by 2031
Read More
Radiation Dose Management Market Worth $749.1 Million by 2029
Read More
Molecular Diagnostics Market Worth $46.69 Billion by 2030
Read More
Newborn Screening Market to be Worth $2.69 Billion by 2031
Read More
Pharmacogenomics Market to be Worth $19.5 Billion by 2031
Read More
Dental Practice Management Software Market Worth $ 3.11 Billion by 2029
Read More
Nepal IVD Market Worth $62.7 Million by 2029
Read More
Pharmaceutical Contract Packaging Market Worth $42.03 Billion by 2029
Read More
Indonesia IVD Market Worth $1.11 Billion by 2029
Read More
Medical Waste Management Market Worth $17.02 billion by 2030
Read More
Empty Capsules Market Worth $4.47 Billion by 2029
Read More
Clear Aligners Market to be worth $18.8 Billion by 2030
Read More
HLA Typing Market Worth $1.9 Billion by 2029
Read More
Real-world Data Market Worth $1.66 billion by 2029
Read More
Track and Trace Solutions Market Worth $27.27 billion by 2029
Read More
Surface Disinfectant Market Worth $9.52 Billion by 2029
Read More
Electronic Lab Notebook Market Worth $787.7 million by 2029
Read More
Rapid Diagnostics Market to be Worth $22.65 Billion By 2031
Read More
Plasma Therapy Market Worth $882.5 Million by 2028
Read More
Peripheral Vascular Devices Market Worth $12.02 Billion by 2028
Read More
Biomaterials Market to Reach 128.7 Billion USD by 2023
Read More
Vaccine Storage Equipment Market Worth $1.83 billion by 2027
Read More
Plasma Fractionation Market Worth $46.9 Billion by 2029
Read More
Home Healthcare Market to be Worth $514.5 Billion by 2030
Read More
Cardiac Pacemaker Devices Market Worth $4.34 Billion by 2028
Read More
European Laboratory Informatics Market Worth $1,084.3 Million By 2024
Read More
Competent Cells Market Worth 2,318.6 Million USD By 2023
Read More
Cancer Immunotherapy Market to be Worth $267.2 Billion by 2030
Read More
Multimodal Imaging Market Worth $1.6 Billion By 2024
Read More
Pulse Lavage Market to be Worth $661.1 Million by 2030
Read More
Medical Cooling Systems Market Worth $2.8 Billion By 2024
Read More
Tissue Diagnostics Market Worth $8.52 Billion by 2029
Read More
Endoscopy Equipment Market Worth $59.8 Billion by 2029
Read More
African Forensic DNA Testing Market Worth $136.3 Million by 2025
Read More
Clinical Trial Supplies Market to be Worth $5.59 Billion by 2031
Read More
Infection Control Market Worth $58.2 Billion by 2027
Read More
Sleep Apnea Devices Market Worth $12.9 billion by 2027
Read More
Medical 3D Printing Market To Reach $983.2 Million By 2020
Read More
Genomics Market to be Worth $70.52 Billion by 2031
Read More
Analytical Standards Market Worth $2.66 Billion By 2027
Read More
Sterilization Equipment Market to be Worth $34.2 Billion by 2035
Read More
Telehealth Market Worth $539.73 Billion by 2029
Read More
Cell Culture Market Worth $48.63 Billion by 2029
Read More
Antimicrobial Coatings Market to be Worth $12.41 Billion by 2031
Read More
Flow Cytometry Market Worth $6.4 Billion by 2027
Read More
Medical Aesthetics Market Worth $29.43 billion by 2029
Read More
Oligonucleotide Synthesis Market Worth $3.9 Billion by 2025
Read More
In Vitro Diagnostics Market to be Worth $116.28 Billion by 2031
Read More
Dental Implants Market Worth $6.52 Billion by 2029
Read More
Active Implantable Devices Market Worth 24.02 Billion USD By 2022
Read More
Ventilators Market to be Worth $13.23 Billion by 2031
Read More
Dialysis Market to be Worth $36.6 Billion by 2031
Read More
Task Trainers Market to Be Worth $2.9 Billion by 2032
Read More
Plasmapheresis Market to be Worth $2.55 Billion by 2030
Read More
Diabetes Care Devices Market Worth $31.9 Billion by 2028
Read More
Clinical Genomics Market Worth 879.0 Million USD By 2023
Read More
IVD Quality Control Market to be Worth $2.28 Billion by 2031
Read More
Laboratory Informatics Market Worth $6.1 Billion by 2030
Read More
Chromatography Data Systems Market to be Worth $1.7 billion by 2030
Read More
Bone Growth Stimulators Market Worth $1.94 Billion by 2030
Read More
Digital Diabetes Market worth $12.03 billion by 2025
Read More
Trocars Market Worth $968.5 Million by 2024
Read More
Healthcare Virtual Assistant Market Worth $1.76 Billion By 2025
Read More
Europe Hospital Beds Market to be Worth $2.09 Billion by 2030
Read More
Immunoassay Market Worth $46.49 Billion by 2028
Read More
Hospital Beds Market to Reach $7.09 Billion by 2031
Read More
Urinalysis Market Worth $2.19 billion by 2027
Read More
Medical Image Management Market Worth $7.22 billion by 2030
Read More
Breast Imaging Market Worth $7.08 Billion by 2027
Read More
VNA & PACS Market to be Worth $6.50 Billion by 2031
Read More